Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Apr 3, 2026

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
08:52

Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

Published on: June 13, 2018

9.4K

Hepatic leiomyosarcoma.

K T Chen

    Journal of Surgical Oncology
    |December 1, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Hepatic leiomyosarcoma, a rare liver tumor, often presents as a mass with abdominal pain or weight loss. Surgical resection offers potential for cure, though prognosis is generally grave.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Anomalous vertebral artery course causing radiculopathy: A case report and review of relevant literature.

    Brain & spine·2026
    Same author

    Generative Adversarial Network-Enhanced Ultra-Low-Dose [<sup>18</sup>F]-PI-2620 τ PET/MRI in Aging and Neurodegenerative Populations.

    AJNR. American journal of neuroradiology·2023
    Same author

    Investigating Simultaneity for Deep Learning-Enhanced Actual Ultra-Low-Dose Amyloid PET/MR Imaging.

    AJNR. American journal of neuroradiology·2022
    Same author

    The Effect of Breast Cancer Subtype on Symptom Improvement Following Palliative Radiotherapy for Bone Metastases.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2021
    Same author

    [Cochleo-vestibular lesions and prognosis in patients with profound sudden sensorineural hearing loss: a comparative analysis].

    Zhonghua er bi yan hou tou jing wai ke za zhi = Chinese journal of otorhinolaryngology head and neck surgery·2020
    Same author

    [Clinical characteristics and etiological analysis of sudden deafness patients with vertigo].

    Zhonghua yi xue za zhi·2019
    Same journal

    Institutional Learning Curve in Esophagectomy: Technical Standardization of Gastric Conduit Formation and Conduit-Related Outcomes in 187 Consecutive Patients.

    Journal of surgical oncology·2026
    Same journal

    Evaluating the Accuracy of ChatGPT-4o in Addressing Complex Clinical Questions Based on NCCN Guidelines for Rectal Adenocarcinoma.

    Journal of surgical oncology·2026
    Same journal

    Racial Differences in Breast Cancer Treatment and Information Access.

    Journal of surgical oncology·2026
    Same journal

    Comparative Analysis of CEM and Breast MRI: A Retrospective Study.

    Journal of surgical oncology·2026
    Same journal

    The Treatment Efficacy for Patients Undergoing Combined Transanal-Transabdominal Endoscopic Resection of Rectal Anastomosis Stenosis.

    Journal of surgical oncology·2026
    Same journal

    "It Depends on the Situation": Variability in How Surgical Oncologists Elicit and Integrate Patient Values.

    Journal of surgical oncology·2026
    See all related articles

    Area of Science:

    • Hepatobiliary pathology
    • Surgical oncology
    • Medical literature review

    Background:

    • Leiomyosarcoma is a rare malignant mesenchymal tumor.
    • Hepatic leiomyosarcoma is an exceptionally rare subtype originating in the liver.
    • Reviewing existing literature and a case report provides insight into this rare entity.

    Observation:

    • Fifteen cases of hepatic leiomyosarcoma were analyzed.
    • The primary presenting symptom was a hepatic or abdominal mass.
    • Associated symptoms included abdominal pain and weight loss in about half of the patients.

    Findings:

    • Elevated serum alkaline phosphatase, SGOT, and LDH were frequent but inconsistent biochemical markers.
    • The overall prognosis for hepatic leiomyosarcoma is poor, with most patients dying within 3 years.

    More Related Videos

    Application of Hemostatic Devices in Laparoscopic Hepatectomy
    04:23

    Application of Hemostatic Devices in Laparoscopic Hepatectomy

    Published on: April 19, 2022

    3.0K
    Robotic Enucleation of Esophageal Leiomyoma
    04:19

    Robotic Enucleation of Esophageal Leiomyoma

    Published on: February 20, 2026

    424

    Related Experiment Videos

    Last Updated: Apr 3, 2026

    Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells
    08:52

    Modeling Osteosarcoma Using Li-Fraumeni Syndrome Patient-derived Induced Pluripotent Stem Cells

    Published on: June 13, 2018

    9.4K
    Application of Hemostatic Devices in Laparoscopic Hepatectomy
    04:23

    Application of Hemostatic Devices in Laparoscopic Hepatectomy

    Published on: April 19, 2022

    3.0K
    Robotic Enucleation of Esophageal Leiomyoma
    04:19

    Robotic Enucleation of Esophageal Leiomyoma

    Published on: February 20, 2026

    424
  • Three patients survived with no evidence of disease for 8 months, 1 year, and 6.5 years, respectively.

    • Implications:

    • Surgical treatment and complete resection are crucial for potential long-term survival.
    • Early diagnosis and intervention are critical for improving outcomes in hepatic leiomyosarcoma.
    • Further research is needed to understand the biology and improve therapeutic strategies for this rare liver cancer.